Can I read Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials on EtoBox?

Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials by Yaxiong Deng; Zijun Wang; Christopher Chang; Liwei Lu; Chak Sing Lau; Qianjin Lu is a Immunology and Microbiology article available to read on EtoBox.

What is Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials about?

Naïve CD4 T cells are pleiotropically divided into various T helper (Th) cell subsets, according to their pivotal roles in the regulation of immune responses. The differentiation of Th9 cells, an interleukin (IL)-9 producing subset, can be impacted by specific environmental cues, co-stimulation with transforming growth factor β (TGF-β) and IL-4, and other regulatory factors. Although IL-9 has been recognized as a classical Th2-related cytokine, recent studies have indicated that IL-9-producing cells contribute to a group of autoimmune disorders including systemic lupus erythematosus (SLE), multiple sclerosis (MS), inflammatory bowel diseases (IBD), rheumatoid arthritis (RA) and psoriasis. Studies of Th9 cells in autoimmune diseases, although in their infancy, are expected to be of growing interest in the study of potential mechanisms of cytokine regulatory pathways and autoimmune pathogenesis. Several in vitro and in vivo pre-clinical trials have been conducted to explore potential therapeutic strategies by targeting the IL-9 pathway. Specifically, anti-IL-9 monoclonal antibodies (mAbs) and IL-9 inhibitors may potentially be used for the clinical treatment of allergic diseases, aut

Who reads Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials?

Author

Yaxiong Deng; Zijun Wang; Christopher Chang; Liwei Lu; Chak Sing Lau; Qianjin Lu

Publisher

Elsevier BV

Published

2017

Language

EN

Field

Immunology and Microbiology (Life Sciences)